Angarayngay, Daryl Jane S.

HRN: 28-52-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2026
AMPICILLIN 1GM (VIAL)
02/08/2026
02/12/2026
IVT
2GMS
Q6
PROM X 3 DAYS
Remove - Pending Acceptance
02/18/2026
CO-AMOXICLAV 625MG (TAB)
02/18/2026
02/24/2026
PO
625
Q8h
SP NSVD; Leukocytosis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: